Clinical Trials · NCT05087342

Latino Semaglutide Study

CompletedPhase 3Semaglutide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Loma Linda University
Enrollment
119
Start date
Dec 2022
Locations
1 site, United States
Primary endpoint
Assessment of weight loss.
View Semaglutide compound reference